全文获取类型
收费全文 | 410724篇 |
免费 | 24901篇 |
国内免费 | 1462篇 |
专业分类
耳鼻咽喉 | 2718篇 |
儿科学 | 12977篇 |
妇产科学 | 14991篇 |
基础医学 | 42064篇 |
口腔科学 | 9953篇 |
临床医学 | 47172篇 |
内科学 | 82286篇 |
皮肤病学 | 6137篇 |
神经病学 | 35817篇 |
特种医学 | 17367篇 |
外国民族医学 | 2篇 |
外科学 | 55354篇 |
综合类 | 5813篇 |
现状与发展 | 17篇 |
一般理论 | 161篇 |
预防医学 | 51744篇 |
眼科学 | 4926篇 |
药学 | 19896篇 |
28篇 | |
中国医学 | 1159篇 |
肿瘤学 | 26505篇 |
出版年
2024年 | 597篇 |
2023年 | 18877篇 |
2022年 | 27008篇 |
2021年 | 29295篇 |
2020年 | 30115篇 |
2019年 | 19668篇 |
2018年 | 20163篇 |
2017年 | 20904篇 |
2016年 | 19705篇 |
2015年 | 17939篇 |
2014年 | 32687篇 |
2013年 | 26902篇 |
2012年 | 16601篇 |
2011年 | 14899篇 |
2010年 | 20131篇 |
2009年 | 18660篇 |
2008年 | 10535篇 |
2007年 | 10254篇 |
2006年 | 8500篇 |
2005年 | 7006篇 |
2004年 | 5955篇 |
2003年 | 5800篇 |
2002年 | 5911篇 |
2001年 | 5473篇 |
2000年 | 4691篇 |
1999年 | 4943篇 |
1998年 | 3622篇 |
1997年 | 2952篇 |
1996年 | 3056篇 |
1995年 | 2572篇 |
1994年 | 1953篇 |
1993年 | 1546篇 |
1992年 | 1924篇 |
1991年 | 1792篇 |
1990年 | 1861篇 |
1989年 | 1485篇 |
1988年 | 1734篇 |
1987年 | 1309篇 |
1986年 | 1054篇 |
1985年 | 743篇 |
1984年 | 942篇 |
1983年 | 733篇 |
1982年 | 807篇 |
1981年 | 719篇 |
1980年 | 592篇 |
1979年 | 370篇 |
1978年 | 398篇 |
1977年 | 331篇 |
1976年 | 268篇 |
1975年 | 164篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
41.
《The journal of sexual medicine》2015,12(3):720-727
IntroductionTreatment satisfaction of men receiving phosphodiesterase 5 inhibitors (PDE5) for erectile dysfunction (ED) and their partners is essential to successful long‐term therapy.AimThis study aims to assess treatment satisfaction, in men with a partial response to on‐demand (PRN) PDE5 and their female partners, following tadalafil 5 mg once daily or placebo.MethodsThe study was randomized, double‐blind, parallel, and placebo‐controlled in men primarily with mild to moderate ED. Treatment satisfaction was assessed following a 4‐week maximum dose PRN lead‐in, 4‐week nondrug washout, and treatment through 12 weeks. Men were ≥18 years old with ED for ≥3 months and International Index of Erectile Function Erectile Function score of ≥17 and <26 at screening and <26 following PRN lead‐in.Main Outcome MeasuresTreatment satisfaction was assessed using the Treatment Satisfaction Scale (TSS) for patients and partners. TSS domain scores range from 0 to 100, with higher values indicating greater satisfaction. Statistical comparisons were made using analysis of covariance.ResultsTreatment satisfaction was significantly greater with tadalafil once daily vs. placebo across all TSS domains for both patients and their partners (all P < 0.001). For patients, mean scores for the TSS domains Confidence to Complete Sexual Activity and Satisfaction with Orgasm ranged from 53.7 to 57.8 after the PRN lead‐in and 26.7 to 31.9 following the nondrug washout. Following randomized treatment, scores for tadalafil and placebo were 55.4 and 32.6, respectively, for Confidence to Complete Sexual Activity and 57.5 and 37.9, respectively, for Satisfaction with Orgasm. Results were comparable for other TSS domains and between men and their partners.ConclusionsTreatment satisfaction was comparable for tadalafil 5 mg once daily and PRN PDE5 for both patients and female partners, suggesting that tadalafil once daily is a viable therapy option for men with ED who had a partial response to PRN PDE5 therapy. Burns PR, Rosen RC, Dunn M, Baygani SK, and Perelman MA. Treatment satisfaction of men and partners following switch from on‐demand phosphodiesterase type 5 inhibitor therapy to tadalafil 5 mg once daily. J Sex Med 2015;12:720–727. 相似文献
42.
43.
44.
45.
46.
47.
48.
Nurse perceptions of the Nursing Delirium Screening Scale in two palliative care inpatient units: a focus group study 下载免费PDF全文
49.
50.
《BONE》2015
Wnt signaling plays key roles in many aspects of development. In this review, we will briefly describe the components of signaling pathways induced by Wnt ligands and then describe the current state of research as this applies to aspects of development and disease as it relates to skeletal muscle and bone. We will conclude with a discussion of the parallels and differences in Wnt signaling in these two contexts and how these pathways are being (or could potentially be) targeted for therapeutic treatment of musculoskeletal diseases.This article is part of a Special Issue entitled “Muscle Bone Interactions”. 相似文献